Medical Marketing and MediaUPDATE 3-FDA approves costly Bristol-Myers drug combo for melanomaReuters... * First-ever approval of immuno-oncology combination - company. * Two-drug combination to cost $256,000 a year. * Drugs separately cost $295,000 a year - cancer specialist (Recasts; adds study details, patient population size). By Bill Berkrot and ...FDA gives early OK to combo cancer treatmentSalt Lake TribuneBristol-Myers Drug Combo Approved by FDA For Skin CancerWKRB NewsFive things for pharma marketers to know: Thursday, October 1, 2015Medical Marketing and MediaMedscapeall 37 news articles »
:)
:(
=(
^_^
:D
=D
|o|
@@,
;)
:-bd
:-d
:p
